Back to Search
Start Over
Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial
- Source :
- Blood; November 2022, Vol. 140 Issue: 1, Number 1 Supplement 1 p523-525, 3p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 140
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs62912705
- Full Text :
- https://doi.org/10.1182/blood-2022-157126